| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.085 | 0.08 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.08 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | 0.057 | 0.08 |
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | 0.093 | 0.08 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.08 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | 0.067 | 0.08 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.058 | 0.08 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.069 | 0.08 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.08 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.14 | 0.08 |